Cargando…
Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature
Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brai...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982616/ https://www.ncbi.nlm.nih.gov/pubmed/24035394 http://dx.doi.org/10.1016/j.celrep.2013.08.011 |
_version_ | 1782311203469524992 |
---|---|
author | Mayes, Debra A. Rizvi, Tilat A. Titus-Mitchell, Haley Oberst, Rachel Ciraolo, Georgianne M. Vorhees, Charles V. Robinson, Andrew P. Miller, Stephen D. Cancelas, Jose A. Stemmer-Rachamimov, Anat O. Ratner, Nancy |
author_facet | Mayes, Debra A. Rizvi, Tilat A. Titus-Mitchell, Haley Oberst, Rachel Ciraolo, Georgianne M. Vorhees, Charles V. Robinson, Andrew P. Miller, Stephen D. Cancelas, Jose A. Stemmer-Rachamimov, Anat O. Ratner, Nancy |
author_sort | Mayes, Debra A. |
collection | PubMed |
description | Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brain white matter tracts correlated with myelin decompaction, downregulation of claudin-11, and mislocalization of connexin-32. Surprisingly, non-cell-autonomous defects in perivascular astrocytes and the blood-brain barrier (BBB) developed, implicating a soluble mediator. Nitric oxide (NO) can disrupt tight junctions and gap junctions, and NO and NO synthases (NOS1–NOS3) were upregulated in mutant white matter. Treating mice with the NOS inhibitor NG-nitro-L-arginine methyl ester or the antioxidant N-acetyl cysteine corrected cellular phenotypes. CNP-HRasG12V mice also displayed locomotor hyperactivity, which could be rescued by antioxidant treatment. We conclude that Nf1/Ras regulates oligodendrocyte NOS and that dysregulated NO signaling in oligodendrocytes can alter the surrounding vasculature. The data suggest that anti-oxidants may improve some behavioral deficits in Rasopathy patients. |
format | Online Article Text |
id | pubmed-3982616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
record_format | MEDLINE/PubMed |
spelling | pubmed-39826162014-04-10 Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature Mayes, Debra A. Rizvi, Tilat A. Titus-Mitchell, Haley Oberst, Rachel Ciraolo, Georgianne M. Vorhees, Charles V. Robinson, Andrew P. Miller, Stephen D. Cancelas, Jose A. Stemmer-Rachamimov, Anat O. Ratner, Nancy Cell Rep Article Patients with neurofibromatosis type 1 (NF1) and Costello syndrome Rasopathy have behavioral deficits. In NF1 patients, these may correlate with white matter enlargement and aberrant myelin. To model these features, we induced Nf1 loss or HRas hyperactivation in mouse oligodendrocytes. Enlarged brain white matter tracts correlated with myelin decompaction, downregulation of claudin-11, and mislocalization of connexin-32. Surprisingly, non-cell-autonomous defects in perivascular astrocytes and the blood-brain barrier (BBB) developed, implicating a soluble mediator. Nitric oxide (NO) can disrupt tight junctions and gap junctions, and NO and NO synthases (NOS1–NOS3) were upregulated in mutant white matter. Treating mice with the NOS inhibitor NG-nitro-L-arginine methyl ester or the antioxidant N-acetyl cysteine corrected cellular phenotypes. CNP-HRasG12V mice also displayed locomotor hyperactivity, which could be rescued by antioxidant treatment. We conclude that Nf1/Ras regulates oligodendrocyte NOS and that dysregulated NO signaling in oligodendrocytes can alter the surrounding vasculature. The data suggest that anti-oxidants may improve some behavioral deficits in Rasopathy patients. 2013-09-12 2013-09-26 /pmc/articles/PMC3982616/ /pubmed/24035394 http://dx.doi.org/10.1016/j.celrep.2013.08.011 Text en ©2013 The Authors http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Article Mayes, Debra A. Rizvi, Tilat A. Titus-Mitchell, Haley Oberst, Rachel Ciraolo, Georgianne M. Vorhees, Charles V. Robinson, Andrew P. Miller, Stephen D. Cancelas, Jose A. Stemmer-Rachamimov, Anat O. Ratner, Nancy Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title | Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title_full | Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title_fullStr | Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title_full_unstemmed | Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title_short | Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature |
title_sort | nf1 loss and ras hyperactivation in oligodendrocytes induce nos-driven defects in myelin and vasculature |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982616/ https://www.ncbi.nlm.nih.gov/pubmed/24035394 http://dx.doi.org/10.1016/j.celrep.2013.08.011 |
work_keys_str_mv | AT mayesdebraa nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT rizvitilata nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT titusmitchellhaley nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT oberstrachel nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT ciraologeorgiannem nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT vorheescharlesv nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT robinsonandrewp nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT millerstephend nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT cancelasjosea nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT stemmerrachamimovanato nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature AT ratnernancy nf1lossandrashyperactivationinoligodendrocytesinducenosdrivendefectsinmyelinandvasculature |